Submission Details
| 510(k) Number | K230135 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 18, 2023 |
| Decision Date | October 04, 2023 |
| Days to Decision | 259 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K230135 is an FDA 510(k) clearance for the Copioumed Chemotherapy Isolation Gown, a Gown, Isolation, Surgical (Class II — Special Controls, product code FYC), submitted by Copioumed International, Inc. (Taipei City, TW). The FDA issued a Cleared decision on October 4, 2023, 259 days after receiving the submission on January 18, 2023. This device falls under the General Hospital review panel. Regulated under 21 CFR 878.4040.
| 510(k) Number | K230135 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 18, 2023 |
| Decision Date | October 04, 2023 |
| Days to Decision | 259 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | FYC — Gown, Isolation, Surgical |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4040 |